Monoclonal Antibodies (DRIP153) Self-Study

Course overview

Monoclonal antibodies are not our grandparents drugs. Monoclonal antibodies (mAb) offer therapeutic interventions for a variety of diseases by targeting specific antigens, from infectious organisms to cellular structures to mediators of inflammation. As a class, the large molecular size of mAb removes many of the risks for adverse effects that characterize small drug molecules. However, as large proteins, many of the principles of pharmacology that we learned do not apply at least in the way we were taught. In this course, learn what you need to know to safely use and educate clients about this game-changing group of drugs, including how and when to report adverse events.